Opaleye Management Inc. Arvinas, Inc. Transaction History
Opaleye Management Inc.
- $364 Million
- Q1 2025
A detailed history of Opaleye Management Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 1,975,000 shares of ARVN stock, worth $16.3 Million. This represents 3.81% of its overall portfolio holdings.
Number of Shares
1,975,000
Previous 1,625,000
21.54%
Holding current value
$16.3 Million
Previous $31.2 Million
55.49%
% of portfolio
3.81%
Previous 6.13%
Shares
8 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.4MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$68.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$51.5 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$31.9 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$31.5 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$27.4 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $438M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...